Search results
Results From The WOW.Com Content Network
Psychomotor agitation is a symptom in various disorders and health conditions. It is characterized by unintentional and purposeless motions and restlessness, often but not always accompanied by emotional distress and is always an indicative for admission.
Lorazepam, sold under the brand name Ativan among others, is a benzodiazepine medication. [14] It is used to treat anxiety (including anxiety disorders ), trouble sleeping , severe agitation , active seizures including status epilepticus , alcohol withdrawal , and chemotherapy-induced nausea and vomiting . [ 14 ]
Benzodiazepines are sometimes prescribed to treat behavioral symptoms of dementia. However, like antidepressants, they have little evidence of effectiveness, although antipsychotics have shown some benefit. [104] [105] Cognitive impairing effects of benzodiazepines that occur frequently in the elderly can also worsen dementia. [106]
The mechanism underlying rapid response to benzodiazepines and zolpidem in catatonia is unknown. [6] The observation that zolpidem, a selective hypnosedative with little to no muscle relaxing properties, elicits a challenge response similar to benzodiazepines has called into question the hypothesis that lorazepam may reverse catatonia through myorelaxation.
An estimated 5.8 million people in the U.S. have Alzheimer’s disease and related dementias, but the condition can be tricky to diagnose.Patients usually are put through a series of tests, and it ...
Researchers from Murdoch University have developed a screening test where people self-report their concerns in six different cognitive areas to help determine a person’s dementia risk.
A simple test for intellectual function, like the Folstein mini–mental state examination, is the minimum screen for dementia. The test requires 15–20 minutes to administer and is available in mental health centers. [8] Diagnosing alcohol-related dementia can be difficult due to the wide range of symptoms and a lack of specific brain ...
A study into the effects of the benzodiazepine receptor antagonist, flumazenil, on benzodiazepine withdrawal symptoms persisting after withdrawal was carried out by Lader and Morton. Study subjects had been benzodiazepine-free for between one month and five years, but all reported persisting withdrawal effects to varying degrees.